Due to COVID-19 therapeutics’ potential for saving lives and reopening the economy, the government has been cutting through red tape to fast track their development. Normally, vaccine development would take several years; FDA drug approvals alone can take six to 10 months. The Administration is looking to find COVID-19 treatments in a fraction of that time, despite potential risks to patients. Key regulatory changes to accomplish this have focused on speeding up the clinical trials, allowing access to investigational drugs and information sharing.

Open document to read more; page 5.